Clariant India Limited
Case brief
What is this about?
The Competition Commission considered a notice under Section 6(2) regarding Clariant India Limited's proposed acquisition of specialty chemical assets from Vivimed Labs Limited. The Commission opined the combination would not have an appreciable adverse effect on competition and approved it under Section 31(1).
What did the court decide?
The proposed combination is approved under sub-section (1) of section 31 of the Act.
What the court decided
A compact analysis
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
COMPETITION COMMISSION OF INDIA
Fair Competition For Greater Good
(Combination Registration No. C-2015/10/323)
16.12.2015
Notice under Section 6 (2) of the Competition Act, 2002 (“Act”) given by Clariant India Limited .
CORAM:
Ashok Chawla Chairperson
S. L. Bunker
Member
Sudhir Mital Member
Augustine Peter Member
U.C. Nahta Member
M.S. Sahoo Member G.P. Mittal Member
Issues for consideration
2 issues framed by the court
Whether the proposed acquisition of specialty chemical assets by Clariant India Limited from Vivimed Labs Limited is likely to have an appreciable adverse effect on competition in India.
Whether the Commission should approve the combination pursuant to Section 31(1) of the Competition Act, 2002.
Parties & counsel
- petitioner
Clariant India Limited
- respondent
Vivimed Labs Limited
Coram
Ashok Chawla
Case details
As recorded by the court registry
Similar cases
Judgements on the same questions, provisions and authorities, from every court